Komo Biosciences
PrivateLast Round
Seed
Jul 9, 2024
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Komo Biosciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in July 2024.
Komo Biosciences is a biotechnology company that provides a next-generation precision genome engineering technology for the development and manufacturing of therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Komo Biosciences Comparables
Compare Komo Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| IntegraTherapeutics | 80% | |
| Stylus Medicine | 77% | |
| Prime Medicine | 76% |
For institutional investors. Book with your work email.
Komo Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Komo Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genesis BioCapital | Seed |
| Eshelman Ventures | Seed |
| LDV Partners | Seed |
| Modi Ventures | Seed |
| General Inception | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 279% MoM, reaching 1.9K.
- Jul 26, 2026
Monthly visitors grew 157% MoM, reaching 493.
For institutional investors. Book with your work email.
Komo Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Komo Biosciences's valuation, stock price, and market status.
Is Komo Biosciences a public or private company?
Komo Biosciences is a private company.
What is the current stock price of Komo Biosciences?
Komo Biosciences is a private company, so its shares have no public market price. Caplight tracks Komo Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Komo Biosciences worth (valuation)?
Valuation information for Komo Biosciences is not publicly available.
Can I buy Komo Biosciences stock?
Komo Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Komo Biosciences's last funding round?
Komo Biosciences's most recent funding round was Seed on July 9, 2024.
Who are the main investors in Komo Biosciences?
Key investors in Komo Biosciences include Genesis BioCapital.
Will Komo Biosciences IPO soon?
No public IPO plans have been announced for Komo Biosciences.
How can I track Komo Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Komo Biosciences's shares on secondary markets.